𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hypersensitivity to plasma exchange in a patient with thrombotic thrombocytopenic purpura

✍ Scribed by Judy Lalmuanpuii; Kiran Yalamanchili; Sophia Fircanis; John C. Nelson


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
84 KB
Volume
24
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

To a limited extent, thrombotic thrombocytopenic purpura (TTP) in addition to its clinical features is being defined nowadays with laboratory tests such as the assay for the Von Willebrand factor‐cleaving protease (ADAMTS 13) and its antibody. We present a case report of a patient with TTP and idiopathic thrombocytopenic purpura (ITP) who had an elevated inhibitor level after plasma exchange. After instituting plasma exchange, patient improved clinically with a platelet count in the normal range. Subsequently, she developed an elevated ADAMTS antibody titer accompanied by a decline in platelet count despite continued exchange. She was successfully treated with a combination of steroids, rituximab and increased dose plasmapheresis. Based on this experience, we conclude that a drop in platelet count while patient is undergoing plasma exchange especially in an initial episode of TTP needs prompt institution of additional therapy to improve outcomes. This case also brings to attention the possibility of an underlying ITP in a patient with an initial diagnosis of TTP. J. Clin. Apheresis, 2009. Β© 2008 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Hemolytic uremic syndrome/thrombotic thr
✍ Dr. Andrew W. Roberts; E. Ann Gillett; Simon J. Fleming πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 420 KB

A retrospective analysis was made of 14 consecutive adults with hemolytic uremic syndromeithrombotic thrombocytopenic purpura (HUSiTTP) who were treated with plasma exchange (PE). In six patients the disease was primary, whilst in eight HUSiTTP was considered secondary to an associated condition. Th

Treatment of thrombotic thrombocytopenic
✍ Dr. Sharda Gupta; James W. Funkhouser πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 399 KB

Five patients with thrombotic thrombocytopenic purpura (TTP) were treated with corticosteroids, plasma exchange (PE), and antiplatelet agents. ABO-and Rh-compatible fresh-frozen plasma (FFP) was used as the replacement fluid. None of the patients received FFP infusion without PE. The patients were

Patients with thrombotic thrombocytopeni
✍ Marisa B. Marques; Shu T. Huang πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 31 KB

## Abstract Thrombotic thrombocytopenic purpura (TTP) and myasthenia gravis (MG) are category I indications for therapeutic plasma exchange (TPE). This study was based on the hypothesis that the development of metabolic alkalosis during TPE is more common in TTP than in MG, based on our previous ob

Durable remissions following prolonged p
✍ R. Ben Dawson; James A. Brown; Kathy Mahalati; Suchada Sapsiri; Steve Pearlman; πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 416 KB

We evaluated the efficacy of prolonged plasma exchange (PEX) for attaining durable remissions in thrombotic thrombocytopenic purpura (lTP). A recent review using steroids or PEX in initial management showed an 80% response rate but produced a relapse rate of 67-84%. Records of 50 patients starting P

Deterioration of gas exchange in patient
✍ Elizabeth M. Kfoury Baz; Mohamad F. Khatib; Rami A.R. Mahfouz; Ghassan W. Jamale πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 83 KB

Therapeutic plasma exchange (TPE) is a procedure performed on patients suffering from various disorders, including thrombotic thrombocytopenic purpura (TTP). As we noted a frequent transient deterioration in respiratory function when the procedure was performed on intensive care unit (ICU) patients,